NCT01331161View on ClinicalTrials.gov

Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

October 31, 2012

Conditions
Shingles
Interventions
BIOLOGICAL

ZOSTAVAX

shingles vaccine, one dose

Trial Locations (2)

30329

Emory University, Atlanta

80045

University of Colorado, Aurora

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Emory University

OTHER

NCT01331161 - Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly | Biotech Hunter | Biotech Hunter